Abstract:Lung cancer (LC) is one of the most common cancer worldwide. Tumor-associated macrophages (TAMs) are important component of the tumor microenvironment (TME) and are closely related to the stages of tumor occurrence, development, and metastasis. Macrophages are plastic and can differentiate into different phenotypes and functions under the influence of different signaling pathways in TME. The classically activated (M1-like) and alternatively activated (M2-like) represent the two polarization states of macrophages. M1 macrophages exhibit anti-tumor functions, while M2 macrophages are considered to support tumor cell survival and metastasis. Macrophage polarization involves complex signaling pathways, and blocking or regulating these signaling pathways to enhance macrophages' anti-tumor effects has become a research hotspot in recent years. At the same time, there have been new discoveries regarding the modulation of TAMs towards an anti-tumor phenotype by synthetic and natural drug components. Nanotechnology can better achieve combination therapy and targeted delivery of drugs, maximizing the efficacy of the drugs while minimizing side effects. Up to now, nanomedicines targeting the delivery of various active substances for reprogramming TAMs have made significant progress. In this review, we primarily provided a comprehensive overview of the signaling crosstalk between TAMs and various cells in the LC microenvironment. Additionally, the latest advancements in novel drugs and nano-based drug delivery systems (NDDSs) that target macrophages were also reviewed. Finally, we discussed the prospects of macrophages as therapeutic targets and the barriers to clinical translation.

Development of anti-cancer drugs for tumor-associated macrophages: a comprehensive review and mechanistic insights

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Mechanistic studies of tumor-associated macrophage immunotherapy

Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)

Anti-tumour strategies aiming to target tumour-associated macrophages.

Targeting tumor-associated macrophages for cancer treatment

Exploring the Tumor Promoting Role of Anti-Tumor Macrophage: a Developmental Perspective

The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy

From Dichotomy to Diversity: Deciphering the Multifaceted Roles of Tumor-Associated Macrophages in Cancer Progression and Therapy.

Tumor-Associated Macrophages: Recent Insights and Therapies

Decoding the spatiotemporal heterogeneity of tumor-associated macrophages

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Targeting Tumor-Associated Macrophages As an Antitumor Strategy.

Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer

Research Progress on the Role of Tumor‑associated Macrophages in Tumor Development and Their Use As Molecular Targets (Review).

Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment

Progress in the Research of Tumor Therapy Aimed at Tumor Associated Macrophages

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy

Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment